• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷公藤红素抑制结直肠癌中的一氧化氮合酶和血管生成途径。

Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer.

机构信息

a Department of Anesthesiology , the First Affiliated Hospital of Xi'an Jiaotong University , Xi'an, China.

b Department of Neurosurgery , Neuroscience Institute, Baylor Scott and White Health , Temple , USA.

出版信息

Free Radic Res. 2019 Mar;53(3):324-334. doi: 10.1080/10715762.2019.1575512. Epub 2019 Feb 18.

DOI:10.1080/10715762.2019.1575512
PMID:30773944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6715291/
Abstract

The thunder god vine (Tripterygium wilfordii Hook. F) is traditionally used for inflammation-related diseases in traditional Chinese medicine. In recent years, celastrol (a natural compound from the root of the thunder god vine) has attracted great interest for its potential anticancer activities. The free radical nitric oxide (NO) is known to play a critical role in colorectal cancer growth by promoting tumour angiogenesis. However, how celastrol influences the NO pathway and its mechanism against colorectal cancer is largely unknown. In this study, we investigated the effects and mechanism of celastrol on nitric oxide synthase (NOS) and the angiogenesis pathway in colorectal cancer. Our data show that celastrol inhibited HT-29 and HCT116 cell proliferation, migration, and NOS activity in the cytoplasm. The antiproliferation activity of celastrol was associated with the inhibition of iNOS and eNOS in colorectal cancer cells. Treatment with celastrol inhibited colorectal cancer cell growth and migration, and was associated with suppression of the expression of key genes (TYMP, CDH5, THBS2, LEP, MMP9, and TNF) and proteins (IL-1b, MMP-9, PDGF, Serpin E1, and TIMP-4) involved in the angiogenesis pathway. In addition, combinational use of celastrol with 5-fluorouracil, salinomycin, 1400 W, and L-NIO showed enhanced inhibition of colorectal cancer cell proliferation and migration. In sum, our study suggests that celastrol could suppress colorectal cancer cell growth and migration, likely through suppressing NOS activity and inhibiting the angiogenesis pathway.

摘要

雷公藤(Tripterygium wilfordii Hook. F)在传统中药中常用于治疗与炎症相关的疾病。近年来,由于其潜在的抗癌活性,来源于雷公藤根部的化合物 celastrol 引起了广泛关注。众所周知,自由基一氧化氮(NO)通过促进肿瘤血管生成在结直肠癌的生长中起关键作用。然而,celastrol 如何影响 NO 途径及其对结直肠癌的作用机制在很大程度上仍是未知的。在本研究中,我们研究了 celastrol 对结直肠癌细胞中一氧化氮合酶(NOS)和血管生成途径的影响及其机制。我们的数据表明,celastrol 抑制了 HT-29 和 HCT116 细胞的增殖、迁移和细胞质中 NOS 的活性。celastrol 的抗增殖活性与结直肠癌细胞中 iNOS 和 eNOS 的抑制有关。celastrol 处理抑制了结直肠癌细胞的生长和迁移,并与关键基因(TYMP、CDH5、THBS2、LEP、MMP9 和 TNF)和蛋白(IL-1b、MMP-9、PDGF、Serpin E1 和 TIMP-4)表达的抑制有关,这些基因和蛋白均参与了血管生成途径。此外,celastrol 与 5-氟尿嘧啶、盐霉素、1400 W 和 L-NIO 联合使用可增强对结直肠癌细胞增殖和迁移的抑制作用。总之,我们的研究表明,celastrol 可能通过抑制 NOS 活性和抑制血管生成途径来抑制结直肠癌细胞的生长和迁移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/f9d312c3b6f7/nihms-1042175-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/b43d985f973c/nihms-1042175-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/1b7fb5265208/nihms-1042175-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/5f125d624293/nihms-1042175-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/63e8629b9035/nihms-1042175-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/8d3aa118b0f1/nihms-1042175-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/f9d312c3b6f7/nihms-1042175-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/b43d985f973c/nihms-1042175-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/1b7fb5265208/nihms-1042175-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/5f125d624293/nihms-1042175-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/63e8629b9035/nihms-1042175-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/8d3aa118b0f1/nihms-1042175-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b40/6715291/f9d312c3b6f7/nihms-1042175-f0006.jpg

相似文献

1
Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer.雷公藤红素抑制结直肠癌中的一氧化氮合酶和血管生成途径。
Free Radic Res. 2019 Mar;53(3):324-334. doi: 10.1080/10715762.2019.1575512. Epub 2019 Feb 18.
2
Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer.一氧化氮合酶抑制剂 1400W 和 L-NIO 抑制结直肠癌的血管生成途径。
Nitric Oxide. 2019 Feb 1;83:33-39. doi: 10.1016/j.niox.2018.12.008. Epub 2018 Dec 24.
3
Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.雷公藤红素是从中国“雷公藤”中提取的一种三萜类化合物,是一种有效的蛋白酶体抑制剂,可抑制裸鼠体内人前列腺癌的生长。
Cancer Res. 2006 May 1;66(9):4758-65. doi: 10.1158/0008-5472.CAN-05-4529.
4
Potent suppression of both spontaneous and carcinogen-induced colitis-associated colorectal cancer in mice by dietary celastrol supplementation.饮食中补充雷公藤红素可有效抑制自发性和致癌物诱导的结肠炎相关结直肠癌在小鼠中的发生。
Carcinogenesis. 2018 Jan 12;39(1):36-46. doi: 10.1093/carcin/bgx115.
5
Celastrol inhibits chondrosarcoma proliferation, migration and invasion through suppression CIP2A/c-MYC signaling pathway.雷公藤红素通过抑制CIP2A/c-MYC信号通路抑制软骨肉瘤的增殖、迁移和侵袭。
J Pharmacol Sci. 2017 May;134(1):22-28. doi: 10.1016/j.jphs.2016.12.007. Epub 2017 Apr 14.
6
Potential Anticancer Effect of Celastrol on Hepatocellular Carcinoma by Suppressing CXCR4-related Signal and Impeding Tumor Growth in Vivo.雷公藤红素通过抑制 CXCR4 相关信号通路及体内抑制肿瘤生长对肝癌的潜在抗癌作用。
Arch Med Res. 2020 May;51(4):297-302. doi: 10.1016/j.arcmed.2020.03.001. Epub 2020 Mar 10.
7
Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling Pathways.雷公藤红素通过下调 NF-κB/COX-2 信号通路抑制结肠癌细胞增殖并诱导其凋亡。
Anticancer Agents Med Chem. 2022;22(10):1921-1932. doi: 10.2174/1871520621666211103103530.
8
Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.雷公藤红素通过启动ROS/Akt/p70S6K信号通路并增强缺氧诱导因子-1α蛋白合成来刺激肿瘤细胞中的缺氧诱导因子-1活性。
PLoS One. 2014 Nov 10;9(11):e112470. doi: 10.1371/journal.pone.0112470. eCollection 2014.
9
Celastrol attenuates inflammatory and neuropathic pain mediated by cannabinoid receptor type 2.雷公藤红素减轻由2型大麻素受体介导的炎性疼痛和神经性疼痛。
Int J Mol Sci. 2014 Aug 6;15(8):13637-48. doi: 10.3390/ijms150813637.
10
Celastrol, an inhibitor of heat shock protein 90β potently suppresses the expression of matrix metalloproteinases, inducible nitric oxide synthase and cyclooxygenase-2 in primary human osteoarthritic chondrocytes.雷公藤红素,一种热休克蛋白 90β 的抑制剂,能够显著抑制原代人骨性关节炎软骨细胞中基质金属蛋白酶、诱导型一氧化氮合酶和环氧化酶-2 的表达。
Eur J Pharmacol. 2013 May 15;708(1-3):1-7. doi: 10.1016/j.ejphar.2013.01.057. Epub 2013 Feb 8.

引用本文的文献

1
An Inhaled Nanoemulsion Encapsulating a Herbal Drug for Non-Small Cell Lung Cancer (NSCLC) Treatment.一种用于治疗非小细胞肺癌(NSCLC)的包裹草药药物的吸入型纳米乳剂。
Pharmaceutics. 2025 Apr 22;17(5):540. doi: 10.3390/pharmaceutics17050540.
2
Recent Trends in anti-tumor mechanisms and molecular targets of celastrol.雷公藤红素的抗肿瘤作用机制及分子靶点的最新研究进展。
Int J Biol Sci. 2024 Oct 7;20(14):5510-5530. doi: 10.7150/ijbs.99592. eCollection 2024.
3
Celastrol ameliorates energy metabolism dysfunction of hypertensive rats by dilating vessels to improve hemodynamics.藜芦醇通过扩张血管改善血液动力学来改善高血压大鼠的能量代谢功能障碍。
J Nat Med. 2024 Jan;78(1):191-207. doi: 10.1007/s11418-023-01759-x. Epub 2023 Nov 30.
4
Combination of Irinotecan and Melatonin with the Natural Compounds Wogonin and Celastrol for Colon Cancer Treatment.联合伊立替康和褪黑素与天然化合物白杨素和雷公藤红素治疗结肠癌。
Int J Mol Sci. 2023 May 31;24(11):9544. doi: 10.3390/ijms24119544.
5
Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy.位点特异性纳米调节剂,可调节细胞凋亡,增强结直肠癌化学-光热治疗效果。
J Nanobiotechnology. 2023 Jan 20;21(1):24. doi: 10.1186/s12951-023-01779-5.
6
Gut microbiota profiling variated during colorectal cancer development in mouse.肠道微生物组图谱在小鼠结直肠癌发展过程中发生变化。
BMC Genomics. 2022 Dec 22;23(Suppl 4):848. doi: 10.1186/s12864-022-09008-3.
7
SHP2 inhibition improves celastrol-induced growth suppression of colorectal cancer.抑制SHP2可增强雷公藤红素对结直肠癌的生长抑制作用。
Front Pharmacol. 2022 Sep 1;13:929087. doi: 10.3389/fphar.2022.929087. eCollection 2022.
8
Celastrol Inhibited Human Esophageal Cancer by Activating DR5-Dependent Extrinsic and Noxa/Bim-Dependent Intrinsic Apoptosis.雷公藤红素通过激活DR5依赖的外源性凋亡和Noxa/Bim依赖的内源性凋亡抑制人食管癌。
Front Pharmacol. 2022 Jun 8;13:873166. doi: 10.3389/fphar.2022.873166. eCollection 2022.
9
Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).气体信号分子在肿瘤微环境中的作用:对癌症化疗的影响(综述)。
Mol Med Rep. 2022 Jul;26(1). doi: 10.3892/mmr.2022.12749. Epub 2022 May 26.
10
Targeted delivery of celastrol to glomerular endothelium and podocytes for chronic kidney disease treatment.将雷公藤红素靶向递送至肾小球内皮细胞和足细胞用于治疗慢性肾脏病。
Nano Res. 2022;15(4):3556-3568. doi: 10.1007/s12274-021-3894-x. Epub 2021 Dec 12.

本文引用的文献

1
Autophagy flux inhibition mediated by celastrol sensitized lung cancer cells to TRAIL‑induced apoptosis via regulation of mitochondrial transmembrane potential and reactive oxygen species.雷公藤红素通过调节线粒体跨膜电位和活性氧诱导自噬流抑制增强肺癌细胞对 TRAIL 诱导的凋亡敏感性。
Mol Med Rep. 2019 Feb;19(2):984-993. doi: 10.3892/mmr.2018.9757. Epub 2018 Dec 12.
2
Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab.两例晚期结直肠癌伴同步肺转移患者采用mFOLFOX6/XELOX联合贝伐单抗治疗后的长期生存病例
Case Rep Oncol. 2018 Aug 29;11(2):601-608. doi: 10.1159/000492568. eCollection 2018 May-Aug.
3
A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32).一项针对已接受根治性切除肝转移灶的结直肠癌患者,比较氟尿嘧啶肝动脉灌注化疗及后续全身化疗与单纯全身化疗的随机III期研究(日本多学科癌症治疗基金会32)
J Cancer Res Ther. 2018 Sep;14(Supplement):S761-S766. doi: 10.4103/0973-1482.179188.
4
The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.肠道微生物群失调对5-氟尿嘧啶治疗结直肠癌疗效的影响。
Biomed Pharmacother. 2018 Dec;108:184-193. doi: 10.1016/j.biopha.2018.08.165. Epub 2018 Sep 13.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.regorafenib 治疗标准治疗后进展的转移性结直肠癌患者:大型、单臂、开放标签 IIIb 期 CONSIGN 研究结果。
Oncologist. 2019 Feb;24(2):185-192. doi: 10.1634/theoncologist.2018-0072. Epub 2018 Sep 6.
7
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer.卡培他滨联合奥沙利铂和贝伐珠单抗,随后卡培他滨和贝伐珠单抗维持治疗用于年龄>75 岁转移性结直肠癌患者。
Clin Colorectal Cancer. 2018 Dec;17(4):e663-e669. doi: 10.1016/j.clcc.2018.07.002. Epub 2018 Jul 4.
8
The safety of ramucirumab for the treatment of colorectal cancer.雷莫芦单抗治疗结直肠癌的安全性。
Expert Opin Drug Saf. 2018 Sep;17(9):945-951. doi: 10.1080/14740338.2018.1506762. Epub 2018 Aug 16.
9
RETRACTED: Tripterine alleviates LPS-induced inflammatory injury by up-regulation of miR-146a in HaCaT cells.撤回:千里光碱通过上调 HaCaT 细胞 miR-146a 缓解 LPS 诱导的炎症损伤。
Biomed Pharmacother. 2018 Sep;105:798-804. doi: 10.1016/j.biopha.2018.05.008. Epub 2018 Jun 15.
10
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer.塞来昔布联合伊立替康、5-氟尿嘧啶和亚叶酸钙治疗既往未治疗的晚期或转移性结直肠癌患者的II期研究。
Am J Clin Oncol. 2018 Dec;41(12):1193-1198. doi: 10.1097/COC.0000000000000465.